September 19, 2017

Dentons Hong Kong's corporate finance team recently represented China International Capital Corporation Hong Kong Securities Limited and Jefferies Hong Kong Limited in connection with the IPO listing of Sisram Medical Ltd., the first ever Israeli company to list on Hong Kong Stock Exchange.

The global offering of 110,000,000 shares seeks to raise approximately US$200 million. The company published its Hong Kong prospectus on 5 September 2017. Dealings in the shares on the Hong Kong Stock Exchange commenced on 19 September 2017.

Sisram Medical Ltd. (Sisram) is a leading global provider of energy-based medical aesthetic treatment systems. Incorporated in Israel in 2013 as a non-wholly owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海復星醫藥(集團)股份有限公司) to acquire Alma Lasers Ltd., Sisram focuses on the design, development and production of energy-based medical aesthetic treatment systems. Sisram will become the first Israeli company to list on the Hong Kong Stock Exchange.

The Dentons Hong Kong team, acting as the joint sponsors and underwriters' legal counsel was led by Gordon Ng and Enoch Wong.

About Dentons

Dentons is the world's largest law firm, delivering quality and value to clients around the globe. Dentons is a leader on the Acritas Global Elite Brand Index, a BTI Client Service 30 Award winner and recognized by prominent business and legal publications for its innovations in client service, including founding Nextlaw Labs and the Nextlaw Global Referral Network. Dentons' polycentric approach and world-class talent challenge the status quo to advance client interests in the communities in which we live and work.